Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao Sells 180,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 180,000 shares of the stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the sale, the chief executive officer directly owned 1,553,100 shares in the company, valued at $20,827,071. This represents a 10.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Alignment Healthcare Trading Down 0.1%

NASDAQ:ALHC opened at $13.37 on Friday. The stock’s 50 day moving average price is $14.65 and its 200 day moving average price is $15.23. The company has a market capitalization of $2.65 billion, a PE ratio of -27.85 and a beta of 1.16. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 2.95. Alignment Healthcare, Inc. has a 52-week low of $7.92 and a 52-week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.07. The firm had revenue of $926.93 million for the quarter, compared to the consensus estimate of $889.83 million. Alignment Healthcare had a negative return on equity of 80.49% and a negative net margin of 3.02%. The firm’s quarterly revenue was up 47.5% compared to the same quarter last year. During the same quarter last year, the business posted ($0.25) EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ALHC. MCF Advisors LLC grew its stake in shares of Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Alignment Healthcare in the 1st quarter valued at approximately $42,000. Amalgamated Bank grew its stake in shares of Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock valued at $65,000 after purchasing an additional 616 shares during the last quarter. RiverPark Advisors LLC purchased a new position in shares of Alignment Healthcare in the 4th quarter valued at approximately $106,000. Finally, Regal Partners Ltd purchased a new position in shares of Alignment Healthcare in the 1st quarter valued at approximately $194,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Stephens raised Alignment Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Robert W. Baird raised their target price on Alignment Healthcare from $17.00 to $22.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 15th. UBS Group raised their target price on Alignment Healthcare from $16.00 to $17.00 and gave the stock a “neutral” rating in a research report on Friday, May 2nd. Finally, Stifel Nicolaus raised their target price on Alignment Healthcare from $18.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, April 8th. One analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $17.17.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.